CBIO
Catalyst Biosciences Inc
Company Overview
| Mkt Cap | $173.66M | Price | $12.75 |
| Volume | 29.29K | Change | +1.92% |
| P/E Ratio | -3.7 | Open | $12.42 |
| Revenue | $75.0K | Prev Close | $12.51 |
| Net Income | $-46.7M | 52W Range | $9.81 - $45.00 |
| Div Yield | N/A | Target | $25.60 |
| Overall | 39 | Value | -- |
| Quality | 34 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyCatalyst Biosciences Inc (CBIO) is a leading Healthcare company in the Biotechnology industry, currently trading at $12.75 with a market capitalization of $173.66 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CBIO with a volume of 29K shares. The stock opened down 0.72% from yesterday's close of $12.51. Current analyst estimates project earnings of $-7.86 per share for this year, with next year targeting $-4.17.
CBIO demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including NWBO, NYMX, OHCS, OMIC.
Key investment considerations for CBIO include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 100.8%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 08:41 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CBIO | $12.75 | +1.9% | 29.29K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Catalyst Biosciences Inc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW